Longer follow-up confirms major improvement in outcome in children and adolescents with Philadelphia chromosome acute lymphoblastic leukaemia treated with continuous imatinib and haematopoietic stem cell transplantation. Results from the Spanish Cooperative Study SHOP/ALL-2005

British Journal of Haematology

Volumn 162, Issue 3, 2013, Pages 419-421

  Rives, Susana ^a   Camós, Mireia ^a   Estella, Jesús ^a   Gómez, Pedro ^b   Moreno, MJosé ^c   Vivanco, José Luis ^d   Melo, Montserrat ^e   Fernández Delgado, Rafael ^f   Verdeguer, Amparo ^g   Fernández Teijeiro, Ana ^h   Lendínez, Francisco ⁱ   López Almaraz, Ricardo ^j   Uriz, José Javier ^k   Badell, Isabel ^l  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL DE SABADELL   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

ⁱ HOSPITAL TORRECÁRDENAS   (Spain)

^j HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^k HOSPITAL DONOSTIA   (Spain)

^l UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

Acute lymphoblastic leukaemia; Children; Imatinib; Philadelphia chromosome; Tyrosine kinase inhibitor

Indexed keywords

IMATINIB;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; EVENT FREE SURVIVAL; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA RELAPSE; OVERALL SURVIVAL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ACUTE LYMPHOBLASTIC LEUKAEMIA; CHILDREN; IMATINIB; PHILADELPHIA CHROMOSOME; TYROSINE KINASE INHIBITOR;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BENZAMIDES; CHILD; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PYRIMIDINES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84880314922     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12373     Document Type: Article

References (8)

1. Aricò, M., Schrappe, M., Hunger, S.P., Carroll, W.L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., Horibe, K., Benoit, Y., Pieters, R., Escherich, G., Silverman, L.B., Pui, C.H. & Valsecchi, M.G. (2010) Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia treated between 1995 and 2005. Journal of Clinical Oncology, 28, 4755-4761.
2. Biondi, A., Schrappe, M., De Lorenzo, P., Castor, A., Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., Li, C.K., Vora, A., Aricò, M., Röttgers, S., Saha, V. & Valsecchi, M.G. (2012) Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. The Lancet Oncology, 13, 936-945.
3. Nishiwaki, S., Miyamura, K., Kato, C., Terakura, S., Ohashi, K., Sakamaki, H., Nakao, S., Harigae, H. & Kodera, Y. (2010) Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemia. Anticancer Research, 30, 2415-2418.
4. Pfeifer, H., Wassmann, B., Bethge, W., Dengler, J., Bornhauser, M. & Stadler, M. (2011) Updated long-term results of a randomized comparison of prophylactic and pre-emptive imatinib following allogeneic stem cell transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). Blood (ASH Annual Meeting Abstracts), 118, 247.
5. Ribera, J.M., Oriol, A., González, M., Vidriales, B., Brunet, S., Esteve, J., Del Potro, E., Rivas, C., Moreno, M.J., Tormo, M., Martín-Reina, V., Sarrá, J., Parody, R., Pérez de Oteyza, J., Bureo, E., Bernal, M.T. & Grupo Español de Trasplante Hemopoyético Groups. (2010) Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial. Haematologica, 95, 87-95.
6. Rives, S., Estella, J., Gómez, P., López-Duarte, M., García de Miguel, P., Verdeguer, A., Moreno, M.J., Vivanco, J.L., Couselo, J.M., Fernández-Delgado, R., Maldonado, M., Tasso, M., López-Ibor, B., Lendínez, F., López-Almaraz, R., Uriz, J., Melo, M., Fernández-Teijeiro, A., Rodríguez, I. & Badell, I. (2011) Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005. British Journal of Haematology, 154, 600-611.
7. Schultz, K.R., Bowman, W.P., Aledo, A., Slayton, W.B., Sather, H., Devidas, M., Wang, C., Davies, S.M., Gaynon, P.S., Trigg, M., Rutledge, R., Burden, L., Jorstad, D., Carroll, A., Heerema, N.A., Winick, N., Borowitz, M.J., Hunger, S.P., Carroll, W.L. & Camitta, B. (2009) Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group study. Journal of Clinical Oncology, 27, 5175-5181.
8. Thomas, D. (2012) Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia. The Lancet Oncology, 13, 860-862.